Sofosbuvir and Velpatasvir for Patients with HCV Infection.
Bar-Ilan University, Safed, Israel nimer.assy@naharia.health.gov.il.
Nimer
N
Assy
Galilee Medical Center, Nahariya, Israel.
Masad
M
Barhoum
D000998:Antiviral Agents / Q000627:therapeutic use*; D002219:Carbamates / Q000627:therapeutic use*; D005260:Female; D016174:Hepacivirus / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006576:Heterocyclic Compounds, 4 or More Rings / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D000069474:Sofosbuvir / Q000627:therapeutic use*
D000998:Antiviral Agents; D002219:Carbamates; D006576:Heterocyclic Compounds, 4 or More Rings; D000069474:Sofosbuvir